<DOC>
	<DOCNO>NCT00755794</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness add Montelukast Sodium ( singulair® ) 10 mg per day inhale corticosteroid adult subject uncontrolled asthma .</brief_summary>
	<brief_title>The Singulair® add-on Study Effectiveness Adding Montelukast Inhaled Corticosteroids Adult Subjects With Uncontrolled Asthma ( 0476-384 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Patients Is 18 Years Old Note 1 : Regulatory Requirements Necessitate The Following Criterion . It May Not Be Appropriate For Your Patients . Female Patients Of Childbearing Potential Should Be Informed Not To Become Pregnant During The Study By Using The Appropriate Contraceptive Methods ( Oral Or LongActing Contraceptive Injections ( Depo Provera ) , Intrauterine Device ( Iud ) , Or Barrier Methods ( E.G . Condom Or Diaphragm Plus Spermicide ) Or To Be Abstinent ( No Sexual Intercourse ) ) Beginning At Least 7 Days Before Visit 1 And Continuing At Least 14 Days After Visit 4 Or A Discontinuation Visit Note 2 : For Alberta : Investigators Who Will Recruit In Private Office , No Patients Can Be Recruited In The Study Until Approval From The College Of Physicians And Surgeons Of Alberta Ethics Committee Is Obtained Patient Is Well Controlled , Adherent And Satisfied With Current Controller Therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>